| 000 | 01536 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250518063308.0 | ||
| 264 | 0 | _c20191209 | |
| 008 | 201912s 0 0 eng d | ||
| 022 | _a1365-3083 | ||
| 024 | 7 |
_a10.1111/sji.12821 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBakacs, Tibor | |
| 245 | 0 | 0 |
_aExploiting autoimmunity unleashed by low-dose immune checkpoint blockade to treat advanced cancer. _h[electronic resource] |
| 260 |
_bScandinavian journal of immunology _cDec 2019 |
||
| 300 |
_ae12821 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents, Immunological _xadministration & dosage |
| 650 | 0 | 4 |
_aAutoimmunity _xdrug effects |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aCTLA-4 Antigen _xantagonists & inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphocyte Activation _xdrug effects |
| 650 | 0 | 4 | _aMolecular Targeted Therapy |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 | _aOff-Label Use |
| 650 | 0 | 4 | _aProof of Concept Study |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 |
_aT-Lymphocytes _xdrug effects |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aMoss, Ralph W | |
| 700 | 1 | _aKleef, Ralf | |
| 700 | 1 | _aSzasz, Marcell A | |
| 700 | 1 | _aAnderson, Colin C | |
| 773 | 0 |
_tScandinavian journal of immunology _gvol. 90 _gno. 6 _gp. e12821 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/sji.12821 _zAvailable from publisher's website |
| 999 |
_c30178975 _d30178975 |
||